(Q61921039)
Statements
Phase I/II Trial of Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS, With or Without Cyclophosphamide, in Patients With Recurrent or Refractory Multiple Myeloma (English)
0 references
30 November 2006
0 references
January 2022
0 references
48
0 references
18 year
0 references